A Core outcome set for childhood epilepsy treated with ketogenic diet therapy ( <scp>CORE‐KDT</scp> study): international parent and health professional consensus

Jennifer H. Carroll*, J. Helen Cross, Mary Hickson, Emma Williams, Val Aldridge, Avril Collinson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Downloads (Pure)

Abstract

OBJECTIVE: Ketogenic diet therapy (KDT) can result in benefits (seizure and non-seizure related) for children with drug resistant epilepsy. However, clinical trials report a wide range of outcomes making synthesis of evidence difficult, and do not adequately reflect parent views on important outcomes for their child. To address this, we established the first international parent, health professional and researcher consensus to develop a core outcome set, guided by the Core Outcome Measures in Effectiveness Trials (COMET) Initiative (COMET registration #1116). METHODS: Ethical approval was granted (London-Surrey REC19/LO/1680). A scoping review and interviews with parents identified a comprehensive list of potentially important outcomes, followed by a two-round online Delphi survey of parents and health professionals to prioritise outcomes of importance for inclusion in a core outcome set. This informed a stakeholder consensus meeting and consultation process to finalise the core outcome set. RESULTS: In total, 97 outcomes were identified; 90 from the scoping review and seven from parent interviews. These were rationalised to 77 by the study advisory group, then rated in the first Delphi round by 49 parents and 96 health professionals who suggested 12 new outcomes for rating in round two. 66% of participants (30 parents and 66 professionals) completed round two, where 22 outcomes met criteria for inclusion. In the consensus meeting (9 parents and 13 professionals), 27 undecided outcomes were discussed and scored; one further outcome reached consensus for inclusion. After consultation and ratification, 14 outcomes across five domains were included in the core outcome set. SIGNIFICANCE: A core outcome set for childhood epilepsy treated with KDT has been developed, incorporating the views of international parents and professionals. Implementation in research and clinical settings will standardise outcome selection and reporting, facilitate data synthesis and ultimately enhance the relevance of outcomes to parents, researchers and health professionals.
Original languageEnglish
Number of pages0
JournalEpilepsia
Volume0
Issue number0
Early online date10 Feb 2023
DOIs
Publication statusPublished - 10 Feb 2023

Fingerprint

Dive into the research topics of 'A Core outcome set for childhood epilepsy treated with ketogenic diet therapy ( <scp>CORE‐KDT</scp> study): international parent and health professional consensus'. Together they form a unique fingerprint.

Cite this